STAAR Surgical Company (NASDAQ:STAA - Get Free Report)'s stock price fell 5.8% on Wednesday . The company traded as low as $26.21 and last traded at $25.54. 76,919 shares were traded during trading, a decline of 93% from the average session volume of 1,166,900 shares. The stock had previously closed at $27.10.
Analyst Upgrades and Downgrades
A number of brokerages recently weighed in on STAA. Mizuho upped their target price on shares of STAAR Surgical from $17.00 to $18.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 16th. Weiss Ratings reissued a "sell (d)" rating on shares of STAAR Surgical in a research note on Wednesday, October 8th. Stifel Nicolaus set a $28.00 price target on shares of STAAR Surgical and gave the stock a "hold" rating in a research note on Thursday, August 7th. Canaccord Genuity Group boosted their price objective on shares of STAAR Surgical from $20.00 to $28.00 and gave the company a "hold" rating in a research report on Wednesday, August 6th. Finally, Piper Sandler raised shares of STAAR Surgical to a "hold" rating in a research report on Wednesday, June 18th. Ten analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Reduce" and a consensus target price of $20.67.
Get Our Latest Report on STAA
STAAR Surgical Trading Down 4.4%
The business's 50-day moving average price is $27.35 and its 200-day moving average price is $21.07. The stock has a market cap of $1.28 billion, a PE ratio of -13.41 and a beta of 0.82.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the company. CWM LLC grew its position in shares of STAAR Surgical by 74.1% in the 2nd quarter. CWM LLC now owns 1,563 shares of the medical instruments supplier's stock worth $26,000 after buying an additional 665 shares during the last quarter. GAMMA Investing LLC boosted its stake in STAAR Surgical by 61.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,856 shares of the medical instruments supplier's stock worth $50,000 after purchasing an additional 706 shares in the last quarter. US Bancorp DE boosted its stake in STAAR Surgical by 1,693.0% in the 1st quarter. US Bancorp DE now owns 2,044 shares of the medical instruments supplier's stock worth $36,000 after purchasing an additional 1,930 shares in the last quarter. Brooklyn Investment Group boosted its stake in STAAR Surgical by 1,564.0% in the 1st quarter. Brooklyn Investment Group now owns 2,679 shares of the medical instruments supplier's stock worth $47,000 after purchasing an additional 2,518 shares in the last quarter. Finally, PNC Financial Services Group Inc. boosted its stake in STAAR Surgical by 691.0% in the 2nd quarter. PNC Financial Services Group Inc. now owns 3,607 shares of the medical instruments supplier's stock worth $61,000 after purchasing an additional 3,151 shares in the last quarter. Hedge funds and other institutional investors own 96.70% of the company's stock.
About STAAR Surgical
(
Get Free Report)
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider STAAR Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STAAR Surgical wasn't on the list.
While STAAR Surgical currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
